Three-dimensional Rotational Angiography: Introduction of an Adjunctive Tool for Successful Transarterial Chemoembolization

Task-based selection of three-dimensional rotational angiography imaging modes using in-house phantom

INTRODUCTION

The presence of two modes of three-dimensional rotational angiography (3DRA), both intended for cranial applications with similar protocol names ('cerebral' and 'head limited' with no explanation on what the phrase 'limited' represent), had caused some degree of difficulty with the clinicians and radiographers on deciding which mode to select for which task. This study was aimed to use an in-house phantom to assist with this clinical issue of 3DRA usage in terms of mode selection.

METHODS

An in-house phantom was used in this study to further analyze and recommend selection. A variety of iodinated contrast agent (ICA) concentrations in the objects were used to simulate clinical images of cranial vessels. The Kerma-area product (KAP) was used as dose metric, while the signal difference to noise ratio (SDNR) of the artificial vessels was employed to represent image quality in terms of contrast. The x-ray spectrum analysis was performed for quantitative evaluation.

RESULTS

The non-standard 'head limited' mode is more suggestible for use. Additionally, the 'low' detail option provides the lowest KAP (due to low tube loading) but provided slightly higher SDNR compared to those from 'normal' detail option. A minimum concentration of 18.5 mg/ml of iodine is required to obtain the comparable SDNR with those of higher concentration when the 'low' detail option is selected.

CONCLUSION

The 'head limited' mode with 'low' detail options is advisable for contrast-enhanced procedures. To ensure proper use of each mode, effective collaboration should be established between clinical users, medical physicists, and manufacturer's technical representatives.

IMPLICATIONS FOR PRACTICE

Selection modes for 3DRA procedures have been made less subjective, following dose and image quality of each mode. Future issues can be addressed by collaborating with medical physicists.

Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities

Hepatocellular carcinoma (HCC) constitutes the fifth most frequent malignancy worldwide and the third most frequent cause of cancer-related deaths. Currently, treatment selection is based on the stage of the disease. Emerging fields such as three-dimensional (3D) printing, 3D bioprinting, artificial intelligence (AI), and machine learning (ML) could lead to evidence-based, individualized management of HCC. In this review, we comprehensively report the current applications of 3D printing, 3D bioprinting, and AI/ML-based models in HCC management; we outline the significant challenges to the broad use of these novel technologies in the clinical setting with the goal of identifying means to overcome them, and finally, we discuss the opportunities that arise from these applications. Notably, regarding 3D printing and bioprinting-related challenges, we elaborate on cost and cost-effectiveness, cell sourcing, cell viability, safety, accessibility, regulation, and legal and ethical concerns. Similarly, regarding AI/ML-related challenges, we elaborate on intellectual property, liability, intrinsic biases, data protection, cybersecurity, ethical challenges, and transparency. Our findings show that AI and 3D printing applications in HCC management and healthcare, in general, are steadily expanding; thus, these technologies will be integrated into the clinical setting sooner or later. Therefore, we believe that physicians need to become familiar with these technologies and prepare to engage with them constructively.

Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases

Three-dimensional (3D) visualization involves feature extraction and 3D reconstruction of CT images using a computer processing technology. It is a tool for displaying, describing, and interpreting 3D anatomy and morphological features of organs, thus providing intuitive, stereoscopic, and accurate methods for clinical decision-making. It has played an increasingly significant role in the diagnosis and management of liver diseases. Over the last decade, it has been proven safe and effective to use 3D simulation software for pre-hepatectomy assessment, virtual hepatectomy, and measurement of liver volumes in blood flow areas of the portal vein; meanwhile, the use of 3D models in combination with hydrodynamic analysis has become a novel non-invasive method for diagnosis and detection of portal hypertension. We herein describe the progress of research on 3D visualization, its workflow, current situation, challenges, opportunities, and its capacity to improve clinical decision-making, emphasizing its utility for patients with liver diseases. Current advances in modern imaging technologies have promised a further increase in diagnostic efficacy of liver diseases. For example, complex internal anatomy of the liver and detailed morphological features of liver lesions can be reflected from CT-based 3D models. A meta-analysis reported that the application of 3D visualization technology in the diagnosis and management of primary hepatocellular carcinoma has significant or extremely significant differences over the control group in terms of intraoperative blood loss, postoperative complications, recovery of postoperative liver function, operation time, hospitalization time, and tumor recurrence on short-term follow-up. However, the acquisition of high-quality CT images and the use of these images for 3D visualization processing lack a unified standard, quality control system, and homogeneity, which might hinder the evaluation of application efficacy in different clinical centers, causing enormous inconvenience to clinical practice and scientific research. Therefore, rigorous operating guidelines and quality control systems need to be established for 3D visualization of liver to develop it to become a mature technology. Herein, we provide recommendations for the research on diagnosis and management of 3D visualization in liver diseases to meet this urgent need in this research field.

Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study

The purpose of this study was to evaluate computed analysis of three-dimensional (3D) cone-beam computed tomography angiography (CTA) of the liver for determination of subsegmental tumor-feeding vessels (FVs). Eighteen consecutive patients underwent transarterial chemoembolization (TACE) from January to October 2008 for 25 liver tumors (15 hepatocellular carcinomas [HCCs] and 10 neuroendocrine metastases). Anteroposterior projection angiogram (two-dimensional [2D]) and 3D cone-beam CTA images were acquired by injection of the common hepatic artery. Retrospectively, FVs were independently identified by three radiology technologists using a software package (S) that automatically determines FVs by analysis of 3D images. Subsequently, three interventional radiologists (IRs) independently identified FVs by reviewing the 2D images followed by examination of the 3D images. Finally, the “ground truth” for the number and location of FVs was obtained by consensus among the IRs, who were allowed to use any imaging―including 2D, 3D, and all oblique or selective angiograms―for such determination. Sensitivities, durations, and degrees of agreement for review of 2D, 3D, and S results were evaluated. Sensitivity of 3D (73%) was higher than 2D (64%) images for identification of FVs (P = 0.036). The sensitivity of S (93%) was higher than 2D (P = 0.02) and 3D (P = 0.005) imaging. The duration for review of 3D imaging was longer than that for 2D imaging (187 vs. 94 s, P = 0.0001) or for S (135 s, P = 0.0001). The degree of agreement between the IRs using 2D and 3D imaging were 54% and 62%, respectively, whereas it was 82% between the three radiology technologists using S. These preliminary data show that computed determination of FVs is both accurate and sensitive.

Utility of C-arm CT in overcoming challenges in patients undergoing Transarterial chemoembolization for hepatocellular carcinoma

Transarterial chemoembolization (TACE) is the well-known treatment for hepatocellular carcinoma. Multiple digital subtraction angiography (DSA) acquisitions in different projections are required to identify difficult arterial feeders. Moreover, the tell-tale tumor blush can be obscured by proximity to lung base, small size of lesion, and breathing artifacts. C-arm CT is a revolutionary advancement in the intervention radiology suite that allows acquisition of data which can be reformatted in multiple planes and volume rendered incorporating both soft tissue and vascular information like multidetector computed tomography (MDCT). These images acquired during the TACE procedure can provide critical inputs for achieving a safe and effective therapy. This case series aims to illustrate the utility of C-arm CT in solving specific problems encountered while performing TACE.

2D versus 3D roadmap for uterine artery catheterization: impact on several angiographic parameters

BACKGROUND

Three-dimensional (3D) roadmap is a recently developed imaging technique used to guide diagnostic and interventional catheter-directed procedures and mainly evaluated for neurovascular procedures. Few data with regard to efficacy and radiation dose are currently available in literature.

PURPOSE

To evaluate the use of 3D roadmap technique as compared with the conventional two-dimensional (2D) roadmap for uterine artery catheterization and embolization during uterine fibroid embolization and assess the potential impact on radiation dose, contrast load, and total procedure time.

MATERIAL AND METHODS

In this prospective study, 40 patients were randomly assigned to the 2D or 3D roadmap technique for uterine artery catheterization. Demographic data, specifically the patient's age, weight, height, pelvic circumference, and total uterine and fibroid volume were recorded. Exposure parameters, contrast load, and procedure time were recorded and organ doses for ovaries and uterus were calculated.

RESULTS

Demographic data did not differ between the groups. Catheterization and embolization of both uterine arteries were feasible in all patients, although in one patient in the 3D group, a focal dissection of the proximal uterine artery occurred. No significant difference in estimated ovarian dose was found in the 3D versus 2D group (P = 0.07). Total procedure time was shorter in the 2D group (P = 0.01) and no difference in total contrast load was seen (P = 0.17).

CONCLUSION

Both roadmap techniques are effective imaging-guided tools for uterine artery catheterization, without difference in terms of radiation exposure or contrast load. The total procedure time is shorter in the 2D group.

Emerging technologies for image guidance and device navigation in interventional radiology

Recent developments in image-guidance and device navigation, along with emerging robotic technologies, are rapidly transforming the landscape of interventional radiology (IR). Future state-of-the-art IR procedures may include real-time three-dimensional imaging that is capable of visualizing the target organ, interventional tools, and surrounding anatomy with high spatial and temporal resolution. Remote device actuation is becoming a reality with the introduction of novel magnetic-field enabled instruments and remote robotic steering systems. Robots offer several degrees of freedom and unprecedented accuracy, stability, and dexterity during device navigation, propulsion, and actuation. Optimization of tracking and navigation of interventional tools inside the human body will be critical in converting IR suites into the minimally invasive operating theaters of the future with increased safety and unsurpassed therapeutic efficacy. In the not too distant future, individual image guidance modalities and device tracking methods could merge into autonomous, multimodality, multiparametric platforms that offer real-time data of anatomy, morphology, function, and metabolism along with on-the-fly computational modeling and remote robotic actuation. The authors provide a concise overview of the latest developments in image guidance and device navigation, while critically envisioning what the future might hold for 2020 IR procedures.

Radiation dose from 3D rotational X-ray imaging: organ and effective dose with conversion factors

The purpose of this study was to measure organ doses and the effective dose (ED) using a three-dimensional rotational X-ray (3D-RX) system and to determine the ED conversion factor from the dose area product (DAP) for skull, spine and biliary protocols. A commercial 3D-RX imaging system was used to simulate the protocols with the adult female anthropomorphic phantom. Twenty MOSFET detectors were used to measure the absorbed doses at various organ locations. The ED was calculated for each protocol and the corresponding DAP was obtained. The skin dose was the highest for all the protocols. The second highest organ doses were those of the brain for the skull, the intestine for the spine and the kidney for the biliary protocol. The ED was 0.4-0.9, 4.2-8.4 and 3.2-4.6 mSv, and the ED conversion factor was 0.06-0.09, 0.18-0.31 and 0.13-0.23 mSv Gy(-1) cm(-2) for each protocol, respectively. This data may be used to estimate the patient ED for those protocols in the 3D-RX.

Imaging in interventional oncology

Medical imaging in interventional oncology is used differently than in diagnostic radiology and prioritizes different imaging features. Whereas diagnostic imaging prioritizes the highest-quality imaging, interventional imaging prioritizes real-time imaging with lower radiation dose in addition to high-quality imaging. In general, medical imaging plays five key roles in image-guided therapy, and interventional oncology, in particular. These roles are (a) preprocedure planning, (b) intraprocedural targeting, (c) intraprocedural monitoring, (d) intraprocedural control, and (e) postprocedure assessment. Although many of these roles are still relatively basic in interventional oncology, as research and development in medical imaging focuses on interventional needs, it is likely that the role of medical imaging in intervention will become even more integral and more widely applied. In this review, the current status of medical imaging for intervention in oncology will be described and directions for future development will be examined.

Balloon-occluded retrograde transvenous obliteration of gastric varices using three-dimensional rotational angiography

The anatomy of the gastric veins and gastric varices is complex, and is difficult to understand even with digital subtraction angiography. In balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices, accurate assessment of the vascular anatomy is essential for successful treatment. Here, we report the case of a patient with gastric varices who was successfully treated with BRTO using three-dimensional rotational angiography.

The usefulness of three-dimensional angiography with a flat panel detector of direct conversion type in a transcatheter arterial chemoembolization procedure for hepatocellular carcinoma: initial experience

The purpose of this study was to assess the usefulness of a three-dimensional (3D) angiography system using a flat panel detector of direct conversion type in treatments with subsegmental transcatheter arterial chemoembolization (TACE) for hepatocellular carcinomas (HCCs). Thirty-six consecutive patients who underwent hepatic angiography were prospectively examined. First, two radiologists evaluated the degree of visualization of the peripheral branches of the hepatic arteries on 3D digital subtraction angiography (DSA). Then the radiologists evaluated the visualization of tumor staining and feeding arteries in 25 patients (30 HCCs) who underwent subsegmental TACE. The two radiologists who performed the TACE assessed whether the additional information provided by 3D DSA was useful for treatments. In 34 (94.4%) of 36 patients, the subsegmental branches of the hepatic arteries were sufficiently visualized. The feeding arteries of HCCs were sufficiently visualized in 28 (93%) of 30 HCCs, whereas tumor stains were sufficiently visualized in 18 (60%). Maximum intensity projection images were significantly superior to volume recording images for visualization of the tumor staining and feeding arteries of HCCs. In 27 (90%) of 30 HCCs, 3D DSA provided additional useful information for subsegmental TACE. The high-quality 3D DSA with flat panel detector angiography system provided a precise vascular road map, which was useful for performing subsegmental TACE of HCCs.

Transcatheter arterial chemoembolization: current technique and future promise

Transarterial chemoembolization is the mainstay of catheter based interventional oncologic therapies. This article describes the history of the procedure, selection of appropriate candidates, technical aspects of procedure performance, results, complications, and appropriate follow-up. In addition, the limitations and challenges of the procedure are outlined. Finally, the reader is introduced to novel and promising techniques and devices that hold future promise for transarterial therapy of malignancies.

Pancreas allografts: comparison of three-dimensional rotational angiography with standard digital subtraction angiography

PURPOSE

To define the role of three-dimensional (3D) rotational angiography (RA) for the evaluation of pancreas allografts and compare 3D RA to standard digital subtraction angiography (DSA).

MATERIALS AND METHODS

DSA and 3D RA were performed in patients with vascular abnormalities diagnosed on contrast medium-enhanced magnetic resonance (MR) angiography. Patency of the allograft vasculature, confidence in the ability to make a therapeutic decision, and value of the study for definition of the optimal projection for an intervention was assessed on a graded scale.

RESULTS

Seventeen standard DSA projections (mean, 3.4; range, 2-6) and 10 3D RA images (mean, 2; range, 1-3) were obtained in five patients. An average iodinated contrast agent dose of 14.4 mL (range, 8-22 mL) was administered for DSA. An average CO2 dose of 54 mL (range, 0-120 mL) was administered for 3D RA. Five 3D RA procedures were timed for the arterial phase and five were timed for the arterial and venous phases. Average contrast agent doses were 17.6 mL (range, 11-22 mL) for arterial 3D RA and 24.4 mL (range, 16-34 mL) for arterial- and venous-phase 3D RA. Of 68 vascular segments available for direct comparison of patency, complete concordance was present in 96%. There was no difference in the reviewers' diagnostic confidence (10 +/- 0 for both techniques). Three-dimensional RA was considered significantly superior for planning the optimal projection for intervention (10 +/- 0 for 3D RA vs 7.2 +/- 1.6 for DSA; P = .0052).

CONCLUSIONS

Three-dimensional RA of pancreatic allografts is feasible and does not differ in accuracy from conventional DSA. It provides similar reviewer confidence in the ability to make an accurate treatment decision, but its key advantage is its superior ability to define the optimal projection for planned endovascular interventions.

Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors

Rotational C-arm angiographic computed tomography (CT) with a flat-panel radiography unit permits three-dimensional (3D) reconstruction of soft tissues and blood vessels. The usefulness of this C-arm technique during transcatheter arterial chemoembolization (TACE) is unknown. The authors analyzed the role of the C-arm technique in 18 patients with unresectable liver tumors during TACE. The technique altered the catheter position anticipated by attending interventional radiologists in seven of the 18 patients (39%; 95% confidence interval [CI]: 20%, 61%) and improved the diagnostic confidence in the selected catheter position in 14 of the 18 patients (78%; 95% CI: 55%, 91%). The technique provides CT-like images that are useful to interventional radiologists during TACE.

Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging

PURPOSE

To prospectively test the hypothesis that transcatheter intraarterial first-pass perfusion (TRIP) magnetic resonance (MR) imaging can depict serial reductions in rabbit liver tumor perfusion during transcatheter arterial embolization (TAE).

MATERIALS AND METHODS

All experiments had institutional animal care and use committee approval. In four rabbits implanted with eight VX2 liver tumors, catheters were positioned in the hepatic arteries with conventional angiographic guidance. After transfer to the MR imaging suite, serial TAE was performed, with approximately 0.5 million 40-120-microm embolic particles injected at each embolic stage. TRIP MR imaging was performed at baseline and after each subsequent embolic stage (10 minutes between stages). Serial TAE and TRIP MR imaging were repeated until stasis. The first-pass time course of signal enhancement was measured in both tumors and hepatic arteries. Tumor area under the curve (AUC) and maximum upslope (MUS) values, each normalized by arterial input, were measured to assess iterative perfusion reduction. Perfusion measurements across TAE stages were compared with paired t tests and linear regression.

RESULTS

AUC decreased from a pre-TAE baseline of 0.408 (95% confidence interval [CI]: 0.330, 0.486) to 0.065 (95% CI: 0.046, 0.085) (P<.001) after TAE. MUS decreased from a pre-TAE baseline of 0.151 (95% CI: 0.121, 0.181) to 0.027 (95% CI: 0.022, 0.031) (P<.001) after TAE. Reductions to AUC and MUS after each embolic stage were statistically significant (P<.006 for each group of paired comparisons). AUC strongly correlated with MUS (r=0.966, P<.001).

CONCLUSION

TRIP MR imaging can depict serial reductions in liver tumor perfusion during TAE. TRIP MR imaging offers the potential to target functional embolic end points during TAE.

Intercepting Radiotherapy Using a Real-Time Tumor-Tracking Radiotherapy System for Highly Selected Patients With Hepatocellular Carcinoma Unresectable With other Modalities

PURPOSE

To assess the clinical outcome of intercepting radiotherapy, in which radiotherapy is delivered only when a tumor in motion enters a target area, using a real-time tumor-tracking radiotherapy (RTRT) system for patients with hepatocellular carcinoma who were untreatable with other modalities because the tumors were adjacent to crucial organs or located too deep beneath the skin surface.

METHODS AND MATERIALS

Eighteen tumors, with a mean diameter of 36 mm, were studied in 15 patients. All tumors were treated on a hypofractionated schedule with a tight margin for setup and organ motion using a 2.0-mm fiducial marker in the liver and the RTRT system. The most commonly used dose of radiotherapy was 48 Gy in 8 fractions. Sixteen lesions were treated with a BED(10) of 60 Gy or more (median, 76.8 Gy).

RESULTS

With a mean follow-up period of 20 months (range, 3-57 months), the overall survival rate was 39% at 2 years after RTRT. The 2-year local control rate was 83% for initial RTRT but was 92% after allowance for reirradiation using RTRT, with a Grade 3 transient gastric ulcer in 1 patient and Grade 3 transient increases of aspartate amino transaminase in 2 patients.

CONCLUSIONS

Intercepting radiotherapy using RTRT provided effective focal high doses to liver tumors. Because the fiducial markers for RTRT need not be implanted into the tumor itself, RTRT can be applied to hepatocellular carcinoma in patients who are not candidates for other surgical or nonsurgical treatments.